News

Warning Symptoms May Foretell HAE Attacks, Study Finds

Warning symptoms, also called prodromes, may foretell where in the body and how intense an attack of hereditary angioedema (HAE) will be, a small study found. Using input from patients, researchers observed that the majority experienced a prodrome before an attack and that almost two-thirds were able to tell…

Takeda Canada Seeks AI, Digital Solutions With Innovation Challenge

With a goal of finding new digital technologies and artificial intelligence (AI) solutions for patients with rare genetic disorders like hereditary angioedema (HAE), and for inflammatory bowel diseases, Takeda Canada has introduced an innovation challenge. Specifically, Takeda Canada is seeking new and breakthrough solutions in early diagnosis, as…

HAE Patients Have High Rate of Cancer, Canadian Study Suggests

People with hereditary angioedema (HAE) commonly have histories of cancer, which raises the possibility that it might predispose a person to develop cancer. These findings were reported in the study “Malignancy and immune disorders in patients with hereditary angioedema,” published in the journal Allergy, Asthma…

Pharming, Sanofi Extend Partnership to Manufacture Ruconest

Pharming Group and Sanofi have renewed an agreement for the manufacturing of Ruconest (conestat alfa), Pharming’s approved treatment for swelling attacks in people with hereditary angioedema (HAE). The two companies have been working together for more than a decade, and now have agreed to extend the collaboration…

Prepare to Light Up Buildings for Rare Disease Day 2022

The National Organization for Rare Disorders (NORD) asks Americans to plan ahead to participate in the Light Up for Rare campaign to raise awareness of rare diseases. NORD is the U.S. sponsor for Rare Disease Day on Feb. 28. The annual awareness day spotlights approximately 7,000…